Rosetta Genomics has named Douglas Sites as its executive vice president of sales and marketing.
Sites previously served as vice president of sales and marketing at Asuragen, a molecular diagnostics firm that develops microRNA-based tests. Before that, he was director of sales in hematology and oncology at PLUS Diagnostics.